Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +24.17%
#4 Velvet Velvet +20.00%
#5 Bedrock Bedrock +18.02%
#6 Nockchain Nockchain +15.67%
#7 Fabric Protocol Fabric Protocol +14.55%
#8 Nillion Nillion +13.82%
#9 Perle Perle +13.30%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
Clasificación en acciones #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
Precio por acción
$0.07
Última sincronización: 2024-11-12
Capitalización bursátil
$1.62M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Peak Bio, Inc. (PKBO)

Categoría

Healthcare
Historial del precio de la acción de Peak Bio, Inc. (PKBO)
Precio más alto de cierre: $0.07 el 2024-11-01

Precio más bajo de cierre: $9.71 el 2021-03-01
Historial del precio de la acción de Peak Bio, Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 -26.66%
2023 -98.23%
2022 -44.81%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE